Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Growth in Short Interest

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 300,482 shares, a growth of 109.3% from the September 30th total of 143,564 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily trading volume, of 92,193 shares, the short-interest ratio is currently 3.3 days.

Analyst Upgrades and Downgrades

Separately, Loop Capital set a $1.00 price objective on Xtant Medical in a research note on Wednesday, September 2nd. Two research analysts have rated the stock with a Buy rating. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $1.00.

Xtant Medical Stock Down 3.5%

Shares of NYSEAMERICAN:XTNT traded down $0.01 during midday trading on Friday, hitting $0.28. 44,518 shares of the company’s stock were exchanged, compared to its average volume of 100,139. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.16 and a quick ratio of 1.05. The company has a market cap of $39.31 million, a PE ratio of -3.50 and a beta of -0.20. The stock has a 50 day moving average price of $0.33 and a 200-day moving average price of $0.46. Xtant Medical has a 12 month low of $0.27 and a 12 month high of $0.95.

Xtant Medical (NYSEAMERICAN:XTNT) last announced its quarterly earnings data on Tuesday, August 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.05). The firm had revenue of $23.03 million during the quarter, compared to the consensus estimate of $24.88 million. Xtant Medical had a negative net margin of 10.17% and a negative return on equity of 23.45%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Xtant Medical stock. AWM Investment Company Inc. purchased a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,976,910 shares of the medical device company’s stock, valued at approximately $2,516,000. AWM Investment Company Inc. owned approximately 4.26% of Xtant Medical at the end of the most recent reporting period. 69.33% of the stock is owned by hedge funds and other institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc is a medical technology company focused on developing, manufacturing and distributing orthobiologic and spinal implant products. Its offerings are designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal tissue.

The company’s product portfolio includes biologic materials such as allograft and other regenerative tissue products, along with spinal implants, interbody devices, fixation systems and related surgical instruments.